Comparative and Relative Effectiveness : A Challenge for Health Systems, Regulators, or Pharmaceutical Companies?
Year of publication: |
2015
|
---|---|
Authors: | Towse, Adrian |
Publisher: |
[2015]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Gesundheitswesen | Health care system | Regulierung | Regulation | Gesundheitspolitik | Health policy | Vergleich | Comparison | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals |
Extent: | 1 Online-Ressource (13 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments December 1, 2014 erstellt |
Other identifiers: | 10.2139/ssrn.2637910 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Woods, Beth, (2024)
-
The economic driven by politics as values : the example of pharmaceuticals in France
Smith, Andy, (2017)
-
Brevets pharmaceutiques, innovations et santé publique
Correa, Carlos María, (2000)
- More ...
-
Theory and implementation of differential pricing for pharmaceuticals
Danzon, Patricia Munch, (2005)
-
If it ain't broke, don't price fix it : the OFT and the PPRS
Towse, Adrian, (2007)
-
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?
Drummond, Michael F., (2012)
- More ...